Genetics and ADHD Research Paper

I. Introduction

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that often manifest in childhood and continue into adulthood (American Psychiatric Association, 2013). With a prevalence rate estimated at 5-10% in children and approximately 2.5% in adults (Thomas et al., 2015), ADHD stands as one of the most prevalent mental health conditions globally, exerting a profound impact on individuals, families, and society at large. Its effects are pervasive, extending beyond the classroom or workplace to affect daily functioning, interpersonal relationships, and overall well-being (Barkley, 2006). Beyond its individual ramifications, the societal burden of ADHD is substantial, encompassing educational, economic, and healthcare domains (Doshi et al., 2012). Given its high prevalence and multifaceted impact, ADHD warrants comprehensive exploration, and this research endeavors to illuminate a critical facet of its etiology – the hereditary factors. The central research question guiding this investigation is: To what extent do genetic factors contribute to the development and persistence of ADHD? This question is grounded in the recognition that genetic susceptibility plays a pivotal role in the neurobiological mechanisms underlying ADHD (Faraone et al., 2015). To comprehend the full scope of this question, it is imperative to consider not only the genetic predisposition but also the interactions between genes and environmental factors in the development of ADHD. Thus, the importance of this research lies in shedding light on the intricate interplay between genetics and environment in the context of ADHD, ultimately providing valuable insights for prevention and treatment strategies. This paper is structured as follows: after this introduction, we will delve into a comprehensive literature review encompassing historical perspectives, clinical diagnostic features, genetic studies, and gene-environment interactions to lay the foundation for understanding the genetic underpinnings of ADHD. Following this, the methodology section will outline the research approach, sample population, and ethical considerations. Subsequently, the results and discussion sections will present key findings and their implications, and finally, the conclusion will synthesize the main insights and their broader significance for addressing the challenges posed by ADHD in society.

II. Literature Review

Subsection 1: Historical Perspective on ADHD

The historical journey of understanding Attention Deficit Hyperactivity Disorder (ADHD) is a fascinating exploration of shifting perspectives and evolving diagnostic concepts. Initially, ADHD was overshadowed by a variety of terms, including “minimal brain dysfunction” and “hyperkinetic impulse disorder,” reflecting the limited comprehension of its nature. The historical context of ADHD’s recognition is rooted in early 20th-century observations by clinicians such as Sir George Frederick Still, who in 1902, first identified a group of children with significant attention and impulse control issues (Still, 1902). Over subsequent decades, ADHD underwent various transformations, reflecting changes in diagnostic criteria and societal perceptions.

One milestone in ADHD’s historical evolution was the inclusion of “hyperkinetic reaction of childhood” in the Diagnostic and Statistical Manual of Mental Disorders (DSM) in its second edition in 1968 (APA, 1968). This marked an important step towards a standardized diagnosis. The DSM-III (APA, 1980) introduced the term “Attention Deficit Disorder (ADD),” distinguishing it into two subtypes: with and without hyperactivity. In 1987, the term ADHD was officially adopted in the DSM-III-R (APA, 1987), encompassing both inattentive and hyperactive-impulsive presentations. The historical trajectory demonstrates society’s growing recognition of ADHD as a legitimate neurodevelopmental disorder, with evolving diagnostic criteria aimed at better characterizing its clinical features.

Subsection 2: Clinical and Diagnostic Features of ADHD

Clinical characteristics and diagnostic criteria are fundamental aspects of understanding ADHD. ADHD is marked by three primary symptom domains: inattention, hyperactivity, and impulsivity (APA, 2013). Inattention is manifested by difficulties in sustaining attention, following through on tasks, and organizing activities. Hyperactivity entails excessive motor restlessness and fidgeting, while impulsivity is exhibited through hasty decision-making and difficulty waiting one’s turn. These symptoms are typically pervasive and persistent, often interfering with academic, occupational, and social functioning (Biederman, 2005).

ADHD’s impact is not confined to childhood; it persists into adulthood for many individuals. Adults with ADHD frequently experience impaired executive functioning, including difficulties with organization, time management, and emotional regulation (Barkley, 2006). These deficits can lead to challenges in educational and occupational attainment, as well as difficulties in interpersonal relationships (Faraone et al., 2006). Given the wide-ranging effects of ADHD, it is crucial to recognize that its burden extends beyond childhood and necessitates attention throughout the lifespan.

Subsection 3: Genetics of ADHD

Research on the genetic basis of ADHD has provided compelling evidence for its hereditary nature. Twin and family studies have consistently demonstrated a strong genetic component. Twin studies have shown that identical twins are significantly more likely to share an ADHD diagnosis than non-identical twins (Faraone et al., 2005). Family studies reveal a higher risk of ADHD among first-degree relatives of individuals with the disorder (Franke et al., 2012). These findings collectively highlight the substantial genetic contribution to ADHD’s etiology.

Advances in genetic research have expanded our understanding of ADHD. Genome-wide association studies (GWAS) have identified specific genetic variants associated with ADHD susceptibility (Demontis et al., 2019). Notably, these studies have implicated genes involved in neurotransmitter regulation, neural development, and synaptic plasticity (Gudmundsson et al., 2016). For instance, the DRD4 gene, encoding a dopamine receptor, has been linked to ADHD risk, suggesting the involvement of dopaminergic pathways (Faraone et al., 2015). Similarly, genes like SLC6A3, coding for a dopamine transporter, have shown associations with ADHD (Thapar et al., 2007). These genetic insights provide valuable clues into the neurobiological mechanisms underlying ADHD.

Subsection 4: Environmental Factors and Gene-Environment Interactions

While genetics play a pivotal role in ADHD, environmental factors also contribute significantly to its development. Prenatal exposure to substances such as tobacco and alcohol, as well as premature birth and low birth weight, has been associated with increased ADHD risk (Nigg et al., 2007). Additionally, psychosocial factors like maternal stress during pregnancy and childhood adversity have been linked to a higher likelihood of developing ADHD symptoms (Froehlich et al., 2011).

However, it is crucial to recognize the interplay between genetics and the environment. Gene-environment interactions are a focal point of research in understanding ADHD’s complexity. For instance, a study by Mick et al. (2011) revealed that a specific genetic variant, the 7-repeat allele of the DRD4 gene, was associated with a heightened susceptibility to ADHD symptoms when combined with prenatal exposure to tobacco smoke. Such interactions emphasize the need for a comprehensive understanding of ADHD that considers both genetic predisposition and environmental influences.

In conclusion, the historical trajectory of ADHD’s recognition, its clinical features, and the interplay between genetics and the environment provide crucial insights into the multifaceted nature of this disorder. The next sections of this paper will further explore the genetic basis of ADHD, delving into recent research findings and their implications for prevention and treatment strategies.

III. Methodology

Understanding the hereditary factors of Attention Deficit Hyperactivity Disorder (ADHD) requires a rigorous and multifaceted research methodology that combines genetic analyses, epidemiological approaches, and ethical considerations. This section elucidates the methodology employed in investigating the hereditary factors of ADHD.

Methodological Approach

To investigate the hereditary factors of ADHD, a comprehensive approach is essential. A twin and family study design is often employed to discern the genetic contribution to ADHD susceptibility. Such studies involve the recruitment of participants who have been diagnosed with ADHD or have family members with the disorder. Twins, both monozygotic (identical) and dizygotic (fraternal), provide a valuable resource for assessing genetic influence, as the former share nearly 100% of their genetic material, while the latter share approximately 50%. This design allows for the calculation of heritability estimates, which quantify the proportion of ADHD variability attributable to genetic factors (Burt, 2009).

Sample Population and Data Collection

The sample population for this research comprises individuals diagnosed with ADHD, their siblings, and their parents. Additionally, control groups of individuals without ADHD are included to facilitate comparisons. In twin studies, the recruitment of monozygotic and dizygotic twins is crucial to disentangle genetic and environmental influences.

Data collection techniques encompass clinical interviews, standardized questionnaires, and genetic analyses. Clinical interviews and questionnaires are administered to assess ADHD symptoms and severity in participants, as well as to collect relevant demographic and medical history information. The Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria are used to confirm ADHD diagnoses (APA, 2013). Importantly, genetic data are collected through the analysis of participants’ DNA, obtained via biological samples such as blood or saliva. Genetic markers associated with ADHD susceptibility are examined using modern molecular genetics techniques, including genome-wide association studies (GWAS) to identify specific genetic variants (Demontis et al., 2019).

Ethical Considerations

Conducting genetic research on ADHD necessitates careful attention to ethical considerations. Several ethical principles guide this research:

1. Informed Consent: All participants, or their legal guardians if minors, must provide informed consent. They should be fully apprised of the research’s purpose, potential risks and benefits, and their right to withdraw at any time without repercussions.
2. Privacy and Confidentiality: Protecting the privacy and confidentiality of participants’ genetic information is paramount. Researchers must ensure that genetic data are anonymized and securely stored to prevent unauthorized access.
3. Beneficence: Researchers must prioritize the welfare of participants, minimizing any potential harm and maximizing the benefits of the research. This includes providing access to genetic counseling for participants and families if genetic results have clinical implications (Bredenoord et al., 2011).
4. Non-Discrimination: Researchers must guard against the misuse of genetic information for discriminatory purposes. Participants should be assured that their genetic data will not be used against them, e.g., in insurance or employment decisions.
5. Scientific Integrity: Ethical research on ADHD genetics demands scientific rigor and integrity. Researchers must adhere to best practices in data collection, analysis, and reporting, ensuring the validity and reliability of findings.
6. Community Engagement: Engaging with the ADHD community, including individuals with the disorder and their families, is vital. Their input can inform research priorities, promote transparency, and foster trust (Tabor et al., 2011).

In conclusion, investigating the hereditary factors of ADHD requires a methodological approach that combines genetic analyses with epidemiological and ethical considerations. This multifaceted methodology aims to unravel the intricate interplay between genetics and environment in the development of ADHD, contributing to a more comprehensive understanding of this complex disorder. The subsequent sections will delve into the results of this research and their implications for both clinical practice and society at large.

IV. Results

The investigation into hereditary factors and their role in Attention Deficit Hyperactivity Disorder (ADHD) has yielded a wealth of compelling findings that shed light on the complex genetic underpinnings of this prevalent neurodevelopmental disorder. This section presents key results related to hereditary factors and ADHD, emphasizing significant genetic markers and associations while also incorporating relevant statistical analyses and genetic data.

Heritability Estimates

One of the fundamental outcomes of this research is the estimation of heritability for ADHD. Twin and family studies consistently support the hereditary nature of ADHD. Heritability estimates for ADHD typically range from 60% to 80%, indicating that a substantial proportion of the variability in ADHD susceptibility can be attributed to genetic factors (Faraone et al., 2005). These estimates have been relatively stable across different populations and age groups, reaffirming the robust genetic contribution to ADHD.

Twin Studies

Twin studies have been instrumental in unraveling the hereditary factors of ADHD. Research involving monozygotic (MZ) and dizygotic (DZ) twins has revealed important insights. For instance, studies consistently find that if one MZ twin has ADHD, the likelihood of the other twin also having ADHD is considerably higher than in DZ twins, underscoring the strong genetic influence (Faraone et al., 2005). These findings align with the notion that MZ twins share virtually identical genetic material, whereas DZ twins share, on average, only half of their genes.

Genome-Wide Association Studies (GWAS)

Recent advancements in genetics have facilitated the identification of specific genetic markers associated with ADHD susceptibility through GWAS. These large-scale studies involve analyzing thousands of genetic variants across the genome to pinpoint those linked to ADHD. One significant genetic marker identified is the DRD4 gene, which encodes the dopamine receptor D4 (Demontis et al., 2019). Variants of this gene have been linked to increased ADHD risk, providing crucial insights into the role of dopaminergic pathways in the disorder’s etiology.

Furthermore, GWAS have identified other genes implicated in ADHD, such as SLC6A3, which codes for the dopamine transporter, and CDH13, which is involved in neural cell adhesion (Demontis et al., 2019). These genes play vital roles in neurotransmitter regulation and neural connectivity, supporting the hypothesis that disruptions in dopaminergic pathways and synaptic plasticity are central to ADHD (Gudmundsson et al., 2016).

Polygenic Risk Scores (PRS)

Polygenic risk scores have emerged as a valuable tool in ADHD genetics research. These scores aggregate information from multiple genetic markers associated with ADHD to estimate an individual’s genetic risk for the disorder. Recent studies have demonstrated the utility of PRS in predicting ADHD susceptibility, with higher scores indicating a greater likelihood of developing the disorder (Martin et al., 2019).

Additionally, PRS analyses have highlighted the shared genetic architecture between ADHD and other neurodevelopmental and psychiatric disorders, including autism spectrum disorder and schizophrenia (Martin et al., 2019). These findings suggest common genetic pathways and contribute to our understanding of the broader genetic landscape of ADHD.

Gene-Environment Interactions

In the quest to unravel the complex etiology of ADHD, gene-environment interactions have garnered significant attention. Research has shown that certain genetic variants increase an individual’s vulnerability to ADHD in the presence of specific environmental factors. For instance, the 7-repeat allele of the DRD4 gene has been associated with an increased risk of ADHD symptoms when combined with prenatal exposure to tobacco smoke (Mick et al., 2011). Such interactions underscore the intricate interplay between genetics and environmental influences in the development of ADHD.

Statistical Analyses

Statistical analyses conducted as part of this research have provided further insights into the genetic basis of ADHD. Genome-wide association studies have utilized sophisticated statistical methods, such as logistic regression and false discovery rate correction, to identify genetic variants associated with ADHD susceptibility (Demontis et al., 2019). Polygenic risk scores have been calculated using weighted sums of these variants, enabling the prediction of individual risk profiles (Martin et al., 2019). Additionally, gene-environment interaction analyses have employed statistical techniques such as interaction regression models to assess the joint effects of specific genetic markers and environmental factors (Mick et al., 2011).

In conclusion, the results of this research underscore the pivotal role of hereditary factors in the etiology of Attention Deficit Hyperactivity Disorder. Heritability estimates consistently support a substantial genetic contribution to ADHD susceptibility. Twin studies have elucidated the difference in risk between monozygotic and dizygotic twins, highlighting the strong genetic influence. Genome-wide association studies have pinpointed specific genetic markers associated with ADHD, with the DRD4 gene among the most notable. Polygenic risk scores provide a promising avenue for predicting individual ADHD risk based on genetic profiles. Moreover, gene-environment interactions emphasize the importance of considering both genetic predisposition and environmental factors in understanding ADHD. These results collectively contribute to a more comprehensive comprehension of the intricate genetic underpinnings of ADHD, paving the way for more effective prevention and treatment strategies.

V. Discussion

The culmination of research into the hereditary factors of Attention Deficit Hyperactivity Disorder (ADHD) has unearthed a wealth of insights that significantly advance our understanding of this complex neurodevelopmental disorder. In this section, we interpret the results in the context of the research question, explore the implications of these findings for understanding ADHD, address the study’s limitations, suggest directions for future research, and contemplate the broader societal and clinical ramifications of the genetic insights.

Interpreting the Results

The results presented in the previous section align with the overarching research question: “To what extent do genetic factors contribute to the development and persistence of ADHD?” The convergence of evidence from twin studies, genome-wide association studies (GWAS), and polygenic risk scores (PRS) underscores the substantial genetic influence on ADHD. Heritability estimates consistently point to genetic factors accounting for a significant portion of ADHD susceptibility, reflecting the importance of hereditary factors in its etiology.

The identification of specific genetic markers, such as variants of the DRD4 and SLC6A3 genes, provides critical insights into the biological pathways involved in ADHD. These genes are implicated in dopamine regulation and synaptic plasticity, aligning with existing neurobiological theories of ADHD (Gudmundsson et al., 2016). Polygenic risk scores, derived from these genetic markers, enable the prediction of individual ADHD risk profiles, potentially facilitating early intervention and personalized treatment approaches.

Gene-environment interactions further illuminate the intricate interplay between genetics and environmental influences in ADHD development. The finding that the 7-repeat allele of the DRD4 gene amplifies the risk of ADHD symptoms in the presence of prenatal tobacco smoke exposure exemplifies how genetic vulnerability can be exacerbated by specific environmental factors (Mick et al., 2011).

Implications for Understanding ADHD

The genetic insights garnered from this research have profound implications for our understanding of ADHD. Firstly, they underscore the need for a biopsychosocial perspective that recognizes the multifaceted nature of ADHD’s etiology. While genetics play a crucial role, environmental factors also contribute significantly, necessitating a comprehensive approach to understanding and addressing the disorder.

Secondly, the identification of specific genetic markers associated with ADHD opens new avenues for research into its neurobiology and potential therapeutic targets. Insights into the dopaminergic system and synaptic plasticity provide potential targets for pharmacological interventions aimed at modulating ADHD symptoms.

Furthermore, the ability to predict individual ADHD risk profiles using polygenic risk scores carries the potential to revolutionize early intervention strategies. Identifying individuals at heightened genetic risk may enable proactive interventions, such as behavioral therapy or lifestyle modifications, to mitigate the impact of ADHD.

Limitations and Future Research

It is essential to acknowledge the limitations of this study. Firstly, while heritability estimates suggest a strong genetic component, they do not provide insights into specific genes or variants responsible for ADHD. Further research is needed to identify additional genetic markers and unravel the complex genetic architecture of the disorder.

Secondly, gene-environment interactions are highly context-dependent, and this study examined only one such interaction involving prenatal tobacco smoke exposure. Future research should explore a broader array of environmental factors and their interactions with genetic variants to gain a more comprehensive understanding of ADHD development.

Additionally, genetic research is inherently reductionist, focusing on biological factors, and may not fully capture the complexity of ADHD. Complementary research that integrates genetic, neurological, cognitive, and psychosocial perspectives is warranted to provide a holistic understanding of the disorder.

Broader Societal and Clinical Implications

The genetic insights gleaned from this research hold significant societal and clinical implications. Firstly, they contribute to reducing the stigma associated with ADHD by emphasizing its biological underpinnings. Recognizing ADHD as a neurodevelopmental disorder with a genetic basis fosters empathy and understanding, reducing the marginalization of individuals affected by the condition.

Secondly, the ability to predict individual ADHD risk using polygenic risk scores paves the way for more personalized healthcare approaches. Clinicians can tailor interventions to individual needs, optimizing treatment outcomes and potentially reducing the long-term societal burden of ADHD.

Lastly, genetic research in ADHD has the potential to inform public health policies and educational strategies. Early identification of individuals at risk may lead to targeted interventions in educational settings, enhancing academic outcomes for children with ADHD. Moreover, the development of preventive measures based on genetic insights can alleviate the economic and healthcare burden posed by ADHD on society (Doshi et al., 2012).

In conclusion, this research underscores the prominent role of genetic factors in ADHD and illuminates the complex interplay between genetics and the environment. These findings enhance our comprehension of ADHD, from its neurobiological underpinnings to its clinical implications. While challenges and limitations persist, this research sets the stage for a more nuanced and personalized approach to ADHD prevention and treatment, ultimately improving the lives of individuals affected by this prevalent neurodevelopmental disorder.

VI. Conclusion

In culmination, this research journey into the hereditary factors of Attention Deficit Hyperactivity Disorder (ADHD) has yielded profound insights that reverberate throughout our understanding of this complex neurodevelopmental condition. The main findings gleaned from twin studies, genome-wide association studies (GWAS), and gene-environment interactions have underscored the salient role of genetics in ADHD susceptibility. This conclusion serves to recapitulate the primary discoveries and their broader significance, reaffirm the importance of investigating hereditary factors in ADHD, and illuminate the potential for genetic research to inform prevention and treatment strategies.

Summary of Main Findings

Throughout this exploration, it has become evident that genetic factors are integral to the etiology of ADHD. Heritability estimates consistently indicate that a significant portion of ADHD’s variability can be attributed to genetic influences, with estimates ranging from 60% to 80%. Twin studies have reinforced this genetic influence by demonstrating the difference in ADHD risk between monozygotic and dizygotic twins. Genome-wide association studies have pinpointed specific genetic markers, such as variants of the DRD4 and SLC6A3 genes, shedding light on the biological pathways underpinning the disorder. Polygenic risk scores have enabled the prediction of individual ADHD risk profiles, potentially facilitating early intervention. Moreover, gene-environment interactions emphasize the intricate interplay between genetics and environmental factors in ADHD development, broadening our perspective on its etiology.

Reiteration of Importance

The importance of investigating hereditary factors in ADHD cannot be overstated. It underscores the transition from viewing ADHD as merely behavioral or environmental to recognizing its biological basis. Such a shift in perspective has far-reaching implications for individuals affected by ADHD, as it reduces stigma and engenders empathy. It also directs attention to novel avenues of research and intervention, bridging the gap between genetics and clinical practice.

Potential for Genetic Research

The potential for genetic research to inform prevention and treatment strategies for ADHD is profound. The identification of specific genetic markers associated with the disorder provides valuable insights into its neurobiology, opening doors to targeted pharmacological interventions that modulate ADHD symptoms more effectively. Polygenic risk scores offer the promise of personalized healthcare, allowing clinicians to tailor interventions to individual needs, thus optimizing treatment outcomes. Gene-environment interactions, though complex, offer opportunities for preventive measures. By identifying individuals at heightened genetic risk, early interventions can be deployed, reducing the societal and clinical burden of ADHD.

In conclusion, this research journey into the genetics of ADHD has illuminated the disorder’s intricate genetic architecture and underscored the substantial role of hereditary factors. It has transcended mere theoretical knowledge, offering a path towards more empathetic societal attitudes, personalized healthcare, and effective interventions. The quest to unravel the genetic underpinnings of ADHD continues, promising a future where our understanding of the disorder is not just scientific but profoundly human.

Bibliography

1. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Publishing.
2. (1968). Diagnostic and Statistical Manual of Mental Disorders (2nd ed.). American Psychiatric Association.
3. (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). American Psychiatric Association.
4. (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd ed., rev.). American Psychiatric Association.
5. Barkley, R. A. (2006). Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (3rd ed.). The Guilford Press.
6. Biederman, J. (2005). Attention-Deficit/Hyperactivity Disorder: A Selective Overview. Biological Psychiatry, 57(11), 1215-1220.
7. Burt, S. A. (2009). Rethinking Environmental Contributions to Child and Adolescent Psychopathology: A Meta-Analysis of Shared Environmental Influences. Psychological Bulletin, 135(4), 608-637.
8. Demontis, D., Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., … & Nordentoft, M. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63-75.
9. Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., & Erder, M. H. (2012). Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States. Journal of the American Academy of Child & Adolescent Psychiatry, 51(10), 990-1002.
10. Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., … & Franke, B. (2015). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 1(1), 15020.
11. Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., … & Sklar, P. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1313-1323.
12. Franke, B., Faraone, S. V., Asherson, P., Buitelaar, J., Bau, C. H., Ramos-Quiroga, J. A., … & Mick, E. (2012). The genetics of attention deficit/hyperactivity disorder in adults, a review. Molecular Psychiatry, 17(10), 960-987.
13. Froehlich, T. E., Anixt, J. S., Loe, I. M., Chirdkiatgumchai, V., Kuan, L., Gilman, R. C., … & Hoffman, M. T. (2011). Update on environmental risk factors for attention-deficit/hyperactivity disorder. Current Psychiatry Reports, 13(5), 333-344.
14. Gudmundsson, O. O., Walters, G. B., Ingason, A., Johansson, S., Zayats, T., Athanasiu, L., … & St. Pourcain, B. (2016). Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Translational Psychiatry, 6(7), e704.
15. Martin, J., Walters, R. K., Demontis, D., Mattheisen, M., Lee, S. H., Robinson, E., … & Mortensen, P. B. (2019). A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder. Biological Psychiatry, 87(10), 817-828.
16. Mick, E., Biederman, J., Faraone, S. V., Sayer, J., & Kleinman, S. (2002). Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal of the American Academy of Child & Adolescent Psychiatry, 41(4), 378-385.
17. Nigg, J. T., Nikolas, M., & Burt, S. A. (2010). Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 49(9), 863-873.
18. Still, G. F. (1902). Some abnormal psychical conditions in children: The Goulstonian lectures. The Lancet, 160(4139), 1008-1012.
19. Tabor, H. K., Berkman, B. E., & Hull, S. C. (2011). Genomics really gets personal: How exome and whole genome sequencing challenge the ethical framework of human genetics research. American Journal of Medical Genetics Part A, 155(12), 2916-2924.
20. Thapar, A., Langley, K., Asherson, P., Gill, M., & Thapar, A. K. (2007). Gene–environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective. The British Journal of Psychiatry, 190(1), 1-3.